|
| Press Releases |
|
 |
|
| Thursday, June 23, 2022 |
|
|
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022). more info >> |
|
| Tuesday, June 14, 2022 |
|
|
Novotech's APAC and USA Leadership Teams at BIO 2022 |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key executives from APAC and the US attend BIO 2022 for meetings with biotechs considering the Asia-Pacific region to expedite their clinical trials. #4907 more info >> |
|
| Wednesday, June 15, 2022 |
|
|
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development |
| The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials ('The Summit'). more info >> |
|
| Thursday, May 5, 2022 |
|
|
Novotech Acquires US CRO NCGS, Expands Global Expertise |
| Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of a service expansion program for its global base of clients. more info >> |
|
| Wednesday, February 9, 2022 |
|
|
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report |
| Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark Survey. more info >> |
|
| Wednesday, August 26, 2020 |
|
|
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year' |
| Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year' in an overnight virtual global ceremony. This is the fourth consecutive year Novotech has been recognized with the prestigious CRO regional award. more info >> |
|
| Monday, July 13, 2020 |
|
|
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region |
| The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on how to advance oncology clinical trials in the Asia-Pacific which is currently attracting 10,000 oncology studies (GlobalData). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Graphene Manufacturing Group Ltd. Announces Upsize of Bought Deal Public Offering for Gross Proceeds of C$6 Million
Aug 22, 2025 23:00 HKT/SGT
|
|
|
Ta Yang Group Holdings Limited Announcing AI Transformation Blueprint
Aug 22, 2025 19:21 HKT/SGT
|
|
|
CaoCao Inc. (2643.HK) Added to Hang Seng Composite Index, Set to Join Hong Kong Stock Connect on Sept 8
Aug 22, 2025 19:51 JST
|
|
|
CITIC Resources Deepens Dual Driver Development Strategy of "Investment + Trading"
Aug 22, 2025 19:28 JST
|
|
|
Everbright Grand China Achieved Revenue of RMB24.5 Million in 2025 1H
Aug 22, 2025 13:26 HKT/SGT
|
|
|
China International Development Corporation acquires strategic 20% stake in NVT
Aug 22, 2025 9:22 JST
|
|
|
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Successfully Carries Out Space Protein Crystallization Experiments 
Aug 22, 2025 3:00 JST
|
|
|
Asia's CX Leaders Are Aligning Strategy Around AI, Efficiency, and Workforce Engagement: Key Insights from Customer Experience Live Show Asia 2025
Aug 21, 2025 22:00 HKT/SGT
|
|
|
NEC digital technologies to empower small-scale producers in Africa in partnership with IFAD
Aug 21, 2025 20:32 JST
|
|
|
Sharp Corporation and Sharp Energy Solutions Corporation Sign Memorandum of Understanding with Mitsui O.S.K. Lines, and AAR Japan for Donation of Solar Modules to Kenya
Aug 21, 2025 20:15 JST
|
|
|
Aiming to Build Battery Ecosystem, Toyota and Mazda Start Tests of Energy Storage System Using Electrified Vehicle Batteries
Aug 21, 2025 19:50 JST
|
|
|
NEC signs Memorandum of Cooperation with the Senegalese government, CFPT-SJ, JICA, and four Japan-based companies for vocational training in Senegal
Aug 21, 2025 19:27 JST
|
|
|
Genes Tech Group Announces 2025 Interim Results, Total revenue increased by 9.40% YoY to approximately NTD585.31 million
Aug 21, 2025 18:22 HKT/SGT
|
|
|
Sharp Corporation and Sharp Energy Solutions Corporation Sign Memorandum of Understanding with Mitsui O.S.K. Lines, and IOM to Advance Cooperation through Renewable Energy
Aug 21, 2025 19:07 JST
|
|
|
Lepu Biopharma (2157.HK) announces 2025 interim results
Aug 21, 2025 14:38 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
